Ticagrelor NOBEL 60 mg
Ticagrelor NOBEL 60 mg is a medicine authorised by Swissmedic under authorisation number 69294. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 August 2024 and the authorisation is limited until 28 August 2029. ATC code B01AC24 places the medicine in the group Antithrombotic agents.
| Authorisation number | 69294 |
|---|---|
| Name | Ticagrelor NOBEL 60 mg |
| Full name | Ticagrelor NOBEL 60 mg, Filmtabletten |
| Authorisation holder | NOBEL Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AC24 |
| First authorisation | 29 August 2024 |
| Authorisation validity | 28 August 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ticagrelor NOBEL 60 mg, Filmtabletten | B | 29 August 2024 |
| 2 | Ticagrelor NOBEL 90 mg, Filmtabletten | B | 29 August 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 56 | Tablette(n) | B01AC24 | 06.03.2. | B |
| 2 | 3 x 56 | Tablette(n) | B01AC24 | 06.03.2. | B |
| 3 | 56 | Tablette(n) | B01AC24 | 06.03.2. | B |
| 4 | 3 x 56 | Tablette(n) | B01AC24 | 06.03.2. | B |
| 5 | 98 | Tablette(n) | B01AC24 | 06.03.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ticagrelor NOBEL 60 mg authorised in Switzerland?
Yes. Ticagrelor NOBEL 60 mg is authorised by Swissmedic under authorisation number 69294, data as of 01 September 2026. The authorisation is limited until 28 August 2029.
Which dispensing category does Ticagrelor NOBEL 60 mg have?
Ticagrelor NOBEL 60 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ticagrelor NOBEL 60 mg?
The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.